📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-ß agonist for treatment of spinal cord injury, in male healthy participants. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15854

PubMed Identifier: 37452623

Publication URI: http://europepmc.org/abstract/MED/37452623

Type: Journal Article/Review

Volume: 89

Parent Publication: British journal of clinical pharmacology

Issue: 12

ISSN: 0306-5251